Next-Generation Endocrine Therapies: Opportunities in ER+/HER2- Breast Cancer Care

Get the latest evidence on next-generation endocrine therapies for ER+/HER- breast cancer and optimal strategies for incorporating these agents into clinical practice with an on-demand webcast, downloadable slides, and an expert summary commentary from a live symposium.

Share

Program Content

Activities

ET in ER+/HER2- Breast Cancer
Navigating Endocrine Therapy and Resistance in ER+/HER2- Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2023

SERDs and Novel ET in ER+/HER2- Breast Cancer
Oral SERDs and Novel Endocrine Therapies: Reshaping the Treatment Landscape for ER+/HER2- Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2023

Activities

Endocrine Therapies for Breast Cancer
Next-Generation Endocrine Therapies: Opportunities in ER+/HER2- Breast Cancer Care
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2023

Expires: December 17, 2024

Activities

Next Gen ET Key Takeaways
Next-Generation Endocrine Therapies for ER+/HER2- Breast Cancer Care: Key Takeaways From Our Recent Symposium in San Antonio
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 20, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca